Get started

China50

Bullish Charts - COVID-19 VaccineGilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company's products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency virus (HIV) infection; and Vosevi, Vemlidy, Epclusa, Harvoni, and Viread products for treating liver diseases. It also provides Yescarta, a chimeric antigen receptor T cell therapy for adult patients with relapsed or refractory large B-cell lymphoma; Zydelig, a kinase inhibitor; Letairis, an oral formulation of an endothelin receptor antagonist for pulmonary arterial hypertension; Ranexa, a tablet to treat chronic angina; and AmBisome, an antifungal agent to treat serious invasive fungal infections. In addition, the company offers its products under the name Cayston, Emtriva, Hepsera, Sovaldi, and Tybost. Further, it develops product candidates for the treatment of viral diseases, inflammatory and fibrotic diseases, and oncology. The company markets its products through its commercial teams; and in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaboration agreements with Bristol-Myers Squibb Company; Janssen Sciences Ireland UC; Japan Tobacco Inc.; Galapagos NV; Second Genome; Gadeta; Carna Biosciences Inc.; Nurix Therapeutics, Inc.; Humanigen, Inc.; Kiniksa Pharmaceuticals, Ltd.; Kyverna Therapeutics, Inc.; Glympse Bio, Inc.; Renown Institute for Health Innovation; Goldfinch Bio, Inc.; Insitro, Inc.; Novo Nordisk A/S; Yuhan Corporation; Kite Pharma, Inc.; oNKo-innate Pty. Ltd.; and Roche Holding AG. The company has partnership with Arcus Biosciences, Inc. to co-develop and co-commercialize next-generation cancer immunotherapies. Gilead Sciences, Inc. was founded in 1987 and is headquartered in Foster City, California. On 07/11/20, Gilead announced its drug Remdesivir can reduce risk of death in COVID-19 patients. On 07/10/20, Former FDA Commissioner Scott Gottlieb said Remdesivir data showed improved COVID-19 Recovery & Reduced Risk of Death by 62%. The COVID-19 drug alone could be a huge revenue boom for Gilead into the future as many countries stockpile & use it. On the Daily Chart, it looks to me like a Pennant has formed with a breakout coming, Bullish Volume, Bullish PMO, Bullish MACD, Bullish RSI, Bullish OBV, Bullish Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:GILDLong
by HotCharts
1
COVID-19 Vaccine, 1st Effective Drug, USA Secures 500,000 DosesHHS secures 500,000 doses of remdesivir. The Trump administration has secured 500,000 doses of remdesivir, the first drug shown to be effective at treating hospitalized coronavirus patients, ensuring these doses will be for U.S. use. This could mean huge profits for GILD. Indicators are starting to turn up, Bullish. Daily Chart is turning Bullish. I think if the stock breaks above the $77.00 range, it's going to spike. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:GILDLong
by HotCharts
4
Bullish Charts - COVID-19 Play, N95 Masks, Robust EarningsAlpha Pro Tech, Ltd., together with its subsidiaries, engages in developing, manufacturing, and marketing a line of disposable protective apparel and infection control, and building supply products in the United States and internationally. The company operates through two segments, Building Supply and Disposable Protective Apparel. The Building Supply segment offers construction weatherization products, such as house wrap, synthetic roof underlayment, and other woven materials. The Disposable Protective Apparel segment provides shoecovers, bouffant caps, gowns, coveralls, lab coats, hoods, and frocks, as well as face masks and face shields. The company provides its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; pharmaceutical markets; and building and re-roofing sites. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada. Today looks like a solid break-out in a down market. Alpha Pro is part of a $15 Billion dollar industry. With N95 masks in high demand, I think there's only one way this stock can go, UP... On 5/6/2020, the company reported earnings of $0.39 up from $0.09. Revenue spiked with 47.5% sales growth. On 5/6/2020, The company announced it was debt free. Not many companies can say they're debt free. 52-Week high is around $41.00 Last earnings report was a blockbuster! The company blew past Wall Street estimates and I think they'll continue blowing past estimates into the future. Indicators are Bullish. Daily Chart looks great. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
AMEX:APTLong
by HotCharts
COVID-19 Play - Closed Over $5.00 - July is Here!On May 15, 2020, Sorrento had this to say about the COVID-19 vaccine they are working on... “We’re actually so impressed with the data,” Ji said. “One of the antibodies is so powerful that at a very low concentration it is able to 100% completely prevent infection or inhibit the infection. In our studies, not even one virus escaped from the antibody.” "Phase 1 trial could start within 1st few days of July" - (It mentions this date in the article) "We anticipate having enough material to start Phase 1 trial in patients in the ICU within two (2) months." - (The article I listed was published in May.) Ji was talking about the COVID-19 vaccine they have been working on with Mount Sinai Health System & the University of Texas Medical Branch which has access to the live virus. Anyone thinking this is not the real deal, you might want to think again. Moderna's stock is sitting at $63.04 (After Hours) - What does Moderna have that Sorrento doesn't have? In the article listed herein, Sorrento said "within 2 months..." We are within those two (2) months now. (End of June or July) Link to article: www.biospace.com Today, SRNE broke out above $5.00 On the daily chart, as of today, the Volume spiked, and the MACD, RSI, Stochastic & Accumulation are all Bullish or trending up Bullish. Is news forthcoming? After watching what the stock price of Moderna did and looking at Sorrento trading at $5.12, to me, the reward far outweighs any risk. Also, I believe Sorrento is waiting for an Emergency Use Label on their COVID-19 test that can give you a positive or negative within 8 minutes. Does Moderna have a test? I don't think so. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
SLong
by HotCharts
3
Bullish Charts - Golden CrossBoston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts. Daily Chart - Golden Cross Stochastic is moving up, Bullish RSI is crossing center line, Bullish Volume just went green on the daily I think the stock is getting ready to move higher. I also think, BSX is one of the cheapest medical device companies in the industry. Long
NYSE:BSXLong
by HotCharts
Bullish Charts - Ready to Explode HigherOrigin Agritech Limited, through its subsidiaries, operates an agricultural biotechnology and an e-commerce platform primarily in the People's Republic of China. The company engages in crop seed breeding and genetic improvement activities. It develops, produces, and distributes hybrid crop seeds, as well as hybrid seed technology. The company also operates an e-commerce platform, which delivers agricultural products comprising agricultural seed products, other agricultural inputs, foods, household products, and other consumer products to farmers through online and mobile ordering. Origin Agritech Limited was founded in 1997 and is headquartered in Beijing, China. From the looks of what I read, SEED is could have approval any day to start growing its biotech corn in China. Looking for a pop soon. Target - $9.00 to $10 Long
NASDAQ:SEEDLong
by HotCharts
Bullish Charts - Golden CrossNIO is a Chinese automobile manufacturer headquartered in Shanghai, specializing in designing and developing electric autonomous vehicles. The company is also involved in the FIA Formula E Championship, the first single-seater, all-electric racing series. NIO recently raised almost $1 Billion of much needed capital. Ahead of the $1 Billion, NIO raised an additional $335 Million through private placements. NIO's deliveries are advancing nicely. I do not want to be out of this stock on the next spike up. The daily chart looks bullish with a clear sign of the Golden Cross, Bullish. The last time we spotted the Golden Cross on the NIO Daily Chart was around January 8, 2020. The stock was trading in the $2.50 range and spiked up. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:NIOLong
by HotCharts
China 50 Reversal PatternThe daily chart of the China 50 gave us a reversal trigger on a Friday. Going forward this week would ideally like to see how the market opens to see if it can give us a pullback. The market structure is apparent. Higher lows and higher highs. We hit a resistance and from here the higher lows (uptrend) began to weaken. From here, we created and confirmed our first lower high with the break of the neckline on the head and shoulders pattern. I would watch to see how price reacts at the 13400 zone, but main target would be 13000.
FOREXCOM:CHINA50Short
by Uncharted-FX
China A50 - pushing towards key support levelsLong OANDA:CN50USD , Like I mentioned in my previous posts, price has formed a higher high and is on its way to test the support levels, as per the trend line. Price hit the support line and closed higher! Look at the RSI. key is to look at price making higher moves and change in RSI back upwards after finding support in the Green zone (in the center) IF the RSI support is breached, then look for other time frames, as price could be indicating break in upward trend that's been forming. Watch out for this space for more action, day to day! Please share a thumbs up if you like what you see and share a comment on this! Cheers
OANDA:CN50USDLong
by LoveForCharts
China A50, longChina A50 gave a buy signal on Nov 1st 2019 on day charts, as indicated on charts. As we see now, price has formed a higher high and we will deep dive into the hourly and monthly charts for cues. Look out for retracements and if price continues to make a higher Low, then treat it an entry point to buy more Adding my earlier studies for different perspectives on charts If you like what you see, please share a thumbs up and a comment in the section below If there is any specific chart to be reviewed, share the details below and I will try and revert at the earliest Lets discuss! Cheers
OANDA:CN50USDLong
by LoveForCharts
Brexit Catalyst for Equity Trade?Before I get into the trade idea, I need to preface that I still believe that US equities will be going higher in the longer term. Not really for any fundamental reasons, but more so that the world is in a bad place and the US looks the best, albeit having a lot of problems. Martin Armstrong calls the US and the US Dollar the prettiest sister out of the three ugly sisters. Also, there will be nowhere to go for yield. We know QE (or QE but not calling it QE is coming) and interest rates will be dropping to 0 because central banks are out of options. Check out my posts linked below where I talk about all these things...predictions are coming true and we are truly in the reset/crisis. With rates at 0, we are at the 'paradigm shift' environment that Ray Dalio has spoken about. Bonds are now being traded not for yield but to sell to another bigger fool. Real Estate historically goes up once the first rate hike occurs. You do not take a mortgage out when you know rates will be dropping lower later. Stocks will be the only place for yield and not only that, the liquidity in this type of macro environment will be appealing. You can get in and get out relatively quickly. So onto the short TRADE idea. Markets are still being affected by geopolitical and other uncertainties. This will affect equities in the short term, but again, as a fund manager money has to be deployed. You cannot hold cash for a long time. This money will go to work and I predict it will go into stocks for the yield factor described above. We found out today at time of writing this idea that Brexit will be delayed until January. I have mentioned how Brexit will likely not happen. It will keep getting delayed and we may very well see a re-vote. There are 3 reasons why Brexit will likely not happen: 1) The British politicians who are part of the European Parliament lose their 6 figure jobs and pensions. Not in their best interest to leave. 2) There will be a European economic/debt crisis. The German taxpayer will not be able to bail out Europe all by themselves. The British tax payer will be required to help. 3) Most importantly, Brexit sets a precedent. European nations like Greece, Spain, Italy and Portugal may get inspired by a deal. Anyhow, the charts are setting up nicely for a move lower. We have been in an uptrend, with higher highs and higher lows, and then price began to stall at a resistance/flip zone or in some cases near all time highs. For the SPX, we are seeing an exhaustion it appears. Would ideally like to see a break below this flip zone with a pattern like a head and shoulders. The Nasdaq already had the break. Would like to see a retest with a confirmed lower high and lower low. Nice strong break. The Nikkei is showing signs of a trend exhaustion here. Need to see if we get the break. The China 50 already had the break. Awaiting for another swing (lower high). The German Dax is at a crucial resistance/flip zone that you can see on the daily chart. Showing signs of exhaustion and potential reversal here. We should cover the FTSE as well, but honestly, no real good pattern/set up for me on the lower time frames. The Daily still has a crucial level below.
FX:SPX500Short
by Uncharted-FX
2
China 50 Head and Shoulders?Seeing some weakness here on the China 50, as the buyers bid to make a new higher low has yet to succeed. If we break this 13800 zone, it will be a break of a flip/support zone. Indicating there is no strength with this break out. Be patient and await for the candle close. Here is how it looks like on the 2 hour chart: The head and shoulders is very clear. Still would await for a nice and strong close below this zone. 13500-600 is where I would see another flip zone acting as support.
FOREXCOM:CHINA50Short
by Uncharted-FX
2
China 50 Possible Head and Shoulders PatternWe have had a recent downtrend to the 13400 zone where it looked like we could see an inverse head and shoulders to the downside. However, we failed to break below. Now we are attempting to create a head and shoulders pattern to the upside. Waiting for a break above 13700 with a nice close. Equities seem to be ready to get a boost from world central markets with the promise of more cheap money. The ECB is tomorrow and they are likely to cut rates even negative and provide more stimulus. The US Federal Reserve is then on tap to do the same next week on the 31st. The Chinese markets may have other issues. Talks of a banking crisis with Baoshang bank, and other economic problems...China's last GDP reading of 6.2% was the lowest in 27 years.
FOREXCOM:CHINA50Long
by Uncharted-FX
CN50 - Possible Head & Shoulder formationOANDA:CN50USD Trade Idea CHN50 - Intraday - We look to Sell at 13650 (stop at 13750) Short term momentum is bearish. Price action has posted a Doji candle and is neutral for short-term sentiment. Bias is mildly bearish today but we need to see a break of 13300 to confirm the downward pressure. In line with the possible early stages of a head & shoulders pattern and the strong rejection of gains, we look to set shorts in anticipation of a swing lower. Our profit targets will be 13350 and 13150 Resistance: 13600 / 13700 / 13800 Support: 13320 / 13250 / 13150
OANDA:CN50USDShort
by Signal_Centre
China's Large Cap: Ready to test the 10 year Highs?With the U.S. - China trade deal developments ongoing and reportedly staying on positive grounds, the stock markets are globally on the rise in 2019. This is a good time to examine how the heavy Chinese companies are performing. FXI is the index that tracks China's stocks with the largest capitalization. On the monthly (1M) chart we see that since the 2009 crash, it has been recovering on Higher Highs and Higher Lows, effectively constructing a Channel Up on 1M (RSI = 56.535, MACD = 0.600, Highs/Lows = 0.3822). These indicators show that it recently hit a low point and is on the early stages of a new bullish leg. On the chart this is evident by the January 2019 bounce on the inner lower Higher Low trend line (indicated in dash). What is also evident are the 1M Support Zone (28.20 - 28.70) and 1M Resistance Zone (52.90 - 54.00). The 1M Resistance Zone is our immediate target although the 10 year Channel Up suggests that it may break it and peak as high as 61.00. In our opinion it is definitely a time to start looking at China's Large Cap more favorably. We have already warned of this upcoming bullish leg on the Shanghai Composite Index on December 2018: ** If you like our free content follow our profile (www.tradingview.com) to get more daily ideas. ** Comments and likes are greatly appreciated.
AMEX:FXILong
by InvestingScope